Tert-butyl 3-[7-(5-fluoro-2-pyridinyl)-4-hydroxy-1,3-benzoxazol-2-yl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate
C22H23FN4O4 — CID 142396388
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 3-[7-(5-fluoro-2-pyridinyl)-4-hydroxy-1,3-benzoxazol-2-yl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate
Tert-butyl 3-[7-(5-fluoro-2-pyridinyl)-4-hydroxy-1,3-benzoxazol-2-yl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate (PubChem CID 142396388) has the molecular formula C22H23FN4O4 and a molecular weight of 426.45 g/mol. Its IUPAC name is tert-butyl 3-[7-(5-fluoro-2-pyridinyl)-4-hydroxy-1,3-benzoxazol-2-yl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 3-[7-(5-fluoro-2-pyridinyl)-4-hydroxy-1,3-benzoxazol-2-yl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate |
|---|---|
| PubChem CID | 142396388 |
| Molecular Formula | C22H23FN4O4 |
| Molecular Weight | 426.45 g/mol |
| Exact Mass | 426.17 |
| IUPAC Name | tert-butyl 3-[7-(5-fluoro-2-pyridinyl)-4-hydroxy-1,3-benzoxazol-2-yl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate |
| SMILES | CC(C)(C)OC(=O)N1C2CC1CN(c1nc3c(O)ccc(-c4ccc(F)cn4)c3o1)C2 |
| InChI | InChI=1S/C22H23FN4O4/c1-22(2,3)31-21(29)27-13-8-14(27)11-26(10-13)20-25-18-17(28)7-5-15(19(18)30-20)16-6-4-12(23)9-24-16/h4-7,9,13-14,28H,8,10-11H2,1-3H3 |
| InChIKey | AFZJCXHBWAYWHN-UHFFFAOYSA-N |
| XLogP | 3.93 |
| TPSA | 91.93 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 426.45 |
| LogP ≤ 5 | 3.93 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142396388 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.